CHICAGO, May 5 (Business Wire) -- ACGT Sdn Bhd (“ACGT”) and Chromatin, Inc. jointly announce their intent to pursue a long term research agreement to develop mini-chromosome technology. Earlier today, Derrik Khoo Sin Huat, CEO of ACGT, a wholly-owned subsidiary of Genting Plantations Berhad, and Dr. Daphne Preuss, CEO of Chromatin, signed a Memorandum of Understanding to solidify the intent of both companies, at a ceremony witnessed by Yang Berhormat Datuk Seri Dr. Maximus Johnity Ongkili, Minister of Science, Technology and Innovation Malaysia (MOSTI). This notable event took place in conjunction with the BIO International Convention taking place in Chicago, a biotechnology conference attended by industry leaders and dignitaries from all over the world.

“This collaborative relationship with ACGT strengthens Chromatin’s business links with Malaysia, which began in late 2008 with an investment from The Malaysian Life Sciences Capital Fund,” said Daphne Preuss. “Genting Plantations Berhad is a leading player in the agricultural sector in Asia, and Chromatin looks forward to a mutually beneficial partnership with ACGT to develop biotech solutions which can increase productivity and enhance value creation for multiple crops,” said Preuss.

“ACGT’s partnership with Chromatin builds on our success in establishing strategic business relationships with innovative technology companies,” said Derrik Khoo. “By joining together, we can leverage the strength of both companies to responsibly produce sustainable agricultural products,” said Khoo.